Evommune, Inc. (EVMN)
Market Closed
16 Oct, 08:00 PM
NYSE NYSE Primary $
5. 17
-0.76
-12.8162%
$
215.21M Market Cap
- P/E Ratio
- Div Yield
986,357 Volume
- Eps
$ 5.93
Previous Close 
Want to track EVMN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Evommune, Inc. (EVMN) Statistics
Valuation metrics
Market Cap 215.21M
Enterprise value 174.9M
Trailing P/E (ttm) -2.21
Forward P/E -
PEG ratio 0.04
Price/Sales (ttm) 22.68
Price/Book (mrq) 0.81
Enterprise Value/Revenue 17.49
Enterprise Value/EBITDA -1.83
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 558K
Average volume (90 days) 452.26K
Price summary
52-Week low 5.09
52-Week high 33.2
Beta -
50-Day moving average 6.25
200-Day moving average 21.58
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -9.47%
Operating margin -10.19%
Operational effectiveness
Return on assets -0.31%
Return on equity -0.63%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.28
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.62
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 5.56
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 11.68%
Book value per share (mrq) 7.68
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
